Dates : 5 -16 April 2021

Location : Virtual (Online)


The aims of the course are:

  • To review immunological mechanisms and molecules targeted by immunotherapeutic strategies and clinical trials.
  • To understand immune-related adverse events occurring with these therapies.
  • To get acquainted with immunological monitoring and biomarkers of immunotherapy.
  • To review potential new immunotherapeutic strategies.



Requirements to apply:

This 9-day virtual course is open to PhD students or postdocs in immunology and fellows in clinical specialties related to immunotherapy, such as clinical immunology, oncology, rheumatology, hematology.

Stable internet is a pre-requisite for applying for the virtual course (facilitated using Zoom). All course activities will be in English.

We invite applicants from Latin American and Caribbean countries with national immunology societies affiliated to ALACI. Students from low to middle income countries working in the area are also invited.

To apply please visit

https://www.immunopaedia.org.za/course-registrations/immuno-colombia-2021/and follow instructions carefully


Deadline for application: 30 November 2020


Luis F García

Gloria Vásquez

Gloria I. Sánchez

(Universidad de Antioquia, Colombia)


Dieter Kabelitz (University of Kiel, Germany)

Michelle Letarte (University of Toronto, Canada)

Clive Gray (University of Cape Town, South Africa)


Olivera Finn (University of Pittsburgh, USA)

Sonia Guedan (Hospital Clinic, Spain)

Dieter Kabelitz (University of Kiel, Germany)

Augusto Ochoa (Louisiana State University, USA)

Klaus Pantel (University Hospital Hamburg, Germany)

Betsy Quackenbush (Elstar Therapeutics Inc, USA)

Carla L Rothlin (Yale University, USA)

Gloria Vásquez (Universidad de Antioquia, Colombia)

Soraya Zorro (MD Anderson Cancer Institute, USA)